← back to search

Jing Li

Hebei Medical University · CN
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Acute Ischemic Stroke Management, Cholangiocarcinoma and Gallbladder Cancer Studies, and Liver physiology and pathology.
h-index
39
citations
5,642
works
314
NIH funding
primary concept
Medicine
email

Recent publications

Global Trends in Ischemic Heart Disease Mortality from 1990 to 2021 and 2036 Projections: Insights from GBD 2021 Data.
2025cited by 5position: contributordoi
The impact of radiation-related lymphocyte recovery on the prognosis of locally advanced esophageal squamous cell carcinoma patients: a retrospective analysis
Radiation Oncology 2025cited by 0position: middledoi
Causal Links Between Renal Function and Cardiac Structure, Function, and Disease Risk.
2024cited by 4position: contributordoi
Aqueous humor cytokine levels in patients with subretinal fibrosis in neovascular age-related macular degeneration
BMC Ophthalmology 2024cited by 4position: lastdoi
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)
Liver Cancer 2022cited by 109position: middledoi
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization
European Radiology 2022cited by 15position: middledoi
Comparison of Postoperative Prognosis Among HBV-Related, HCV-Related, and Non-HBV Non-HCV Hepatocellular Carcinomas: A Systematic Review and Meta-analysis
Hepatitis Monthly 2022cited by 2position: middledoi
rSjP40 Inhibited the Activity of Collagen Type I Promoter via Ets-1 in HSCs
Frontiers in Cell and Developmental Biology 2021cited by 11position: firstdoi
Human amniotic membrane allograft, a novel treatment for chronic diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials.
2020cited by 27position: contributordoi
Efficacy and safety of recombinant human epidermal growth factor for diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials.
2020cited by 17position: contributordoi
Efficacy of interventions for amblyopia: a systematic review and network meta-analysis.
2020cited by 13position: contributordoi
Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study
World Journal of Gastroenterology 2020cited by 11position: middledoi
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
Journal of Hepatology 2019cited by 262position: middledoi
Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis.
2019cited by 72position: contributordoi
Incomplete tumor capsule on preoperative imaging reveals microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis.
2019cited by 33position: contributordoi
Study of the Treatment Effects of Compound Tufuling Granules in Hyperuricemic Rats Using Serum Metabolomics
Evidence-based Complementary and Alternative Medicine 2018cited by 14position: middledoi
Bipolar diagnosis in China: Evaluating diagnostic confidence using the Bipolarity Index
Journal of Affective Disorders 2016cited by 14position: middledoi
Tumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death
International Journal of Molecular Medicine 2015cited by 60position: middledoi
The impact of inflammatory cells in malignant ascites on small intestinal ICCs' morphology and function
Journal of Cellular and Molecular Medicine 2015cited by 11position: firstdoi
Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies
PLoS ONE 2014cited by 338position: lastdoi
Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice
Journal of Ethnopharmacology 2014cited by 51position: middledoi
[Etiology analysis of incident hemodialysis patients in Shanxi province during 2010 and 2013].
PubMed 2014cited by 5position: middle
URic Acid and Risk Of Heart Failure: A Systematic Review and Meta-Analysis
European Journal of Heart Failure 2013cited by 329position: middledoi
Circulating suPAR in Two Cohorts of Primary FSGS
Journal of the American Society of Nephrology 2012cited by 219position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2020–2025)Ji Wang · Xuzhou Medical College2 papers (2013–2014) · 2 papers (2013–2014)Jianrong Chen · Nanchang University2 papers (2013–2014)He Huang · Hunan University2 papers (2013–2014)Ting Wang · Sichuan University West China Hospital2 papers (2024–2025)Ke Lin · Springer Nature2 papers (2024–2025)Weiqiang Ruan · Sichuan University2 papers (2024–2025)Xiaoqin Zhou · Sichuan University2 papers (2024–2025)Huizhen Liu · 2 papers (2024–2025) · 2 papers (2014–2018)Min Wang · Chengdu University of Traditional Chinese Medicine1 papers (2024–2024)Yajing Wang · Hebei Medical University1 papers (2025–2025) · 1 papers (2016–2016)Tiantian Zhang · Fudan University1 papers (2024–2024)Zhigang Liu · Fujian Medical University1 papers (2014–2014)Ling Wang · Sun Yat-sen University Cancer Center1 papers (2014–2014)Ping Zhang · Hebei Medical University1 papers (2025–2025)Bei Zhang · Hubei University of Automotive Technology1 papers (2021–2021)Haichen Yang · Shanghai University of Traditional Chinese Medicine1 papers (2016–2016)